A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

Supergen Inc.

About Supergen Inc

SuperGen is a pharmaceutical company dedicated to the development and commercialization of therapies for solid tumors, hematological malignancies and blood disorders.

SuperGen currently has three anti-cancer drugs approved for use, another three either already in Phase III trials or soon expected to be entering Phase III trials, and a broad portfolio of other cancer drugs in various stages of development.




Nipent® is a chemotherapy agent currently indicated for the treatment of hairy cell leukemia. Multiple clinical trials are currently ongoing for other disease states --(bone marrow transplant patients with acute Graft-Vs.-Host Disease)

Mitomycin is SuperGen's generic brand of the chemotherapy agent Mutamycin®.

Orathecin --Orathecin (rubitecan) is an orally active camptothecin; a topoisomerase I inhibitor that was developed for the treatment of pancreatic cancer.

Avicine -- colorectal cancer


More About Supergen

Home Page

Key Statistics for Supergen

Basic Chart for Supergen

Analyst Opinion

Analysts Estimates


Biotech100 Index
· What are the Requirements to be listed in the Biotech100 Index?
· See the Biotech100 List

Sponsored Links

Clinical Trials
· What is a Clinical Trial?
·Phase I ,-- Phase II, -- PhaseIII
·What is Randomized Control?
 What is a Double Blind Experiment?
·What is the role of the FDA?


Key Biotech Terms


Biotech Resources


Investing in Stocks
· Small Cap Stocks
· Stocks and Bonds
· Biotech100 Index

Careers and Employment
· Biotechnology and Pharmaceutical
· What are the Fastest Growing Careers?




Copyright © 2005 BIOTECH100.COM. All rights reserved.